AU2003286499A1 - Interference with c-maf function in multiple myeloma - Google Patents
Interference with c-maf function in multiple myelomaInfo
- Publication number
- AU2003286499A1 AU2003286499A1 AU2003286499A AU2003286499A AU2003286499A1 AU 2003286499 A1 AU2003286499 A1 AU 2003286499A1 AU 2003286499 A AU2003286499 A AU 2003286499A AU 2003286499 A AU2003286499 A AU 2003286499A AU 2003286499 A1 AU2003286499 A1 AU 2003286499A1
- Authority
- AU
- Australia
- Prior art keywords
- interference
- multiple myeloma
- maf
- function
- maf function
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1135—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against oncogenes or tumor suppressor genes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- Hospice & Palliative Care (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2003/033162 WO2005046731A1 (en) | 2003-10-17 | 2003-10-17 | Interference with c-maf function in multiple myeloma |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003286499A1 true AU2003286499A1 (en) | 2004-06-06 |
AU2003286499A8 AU2003286499A8 (en) | 2005-06-06 |
Family
ID=34589281
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003286499A Abandoned AU2003286499A1 (en) | 2003-10-17 | 2003-10-17 | Interference with c-maf function in multiple myeloma |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003286499A1 (en) |
WO (1) | WO2005046731A1 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008045955A2 (en) | 2006-10-10 | 2008-04-17 | Mayo Foundation For Medical Education And Research | Inhibiting cyclin d polypeptides |
KR101944555B1 (en) | 2010-10-06 | 2019-02-01 | 펀다시오 인스티튜트 드 르세르카 바이오메디카(아이알비 바르셀로나) | Method for the diagnosis, prognosis and treatment of breast cancer metastasis |
EP2650682A1 (en) | 2012-04-09 | 2013-10-16 | Fundació Privada Institut de Recerca Biomèdica | Method for the prognosis and treatment of cancer metastasis |
BR112014030750A2 (en) | 2012-06-06 | 2017-08-22 | Inst Catalana Recerca Estudis Avancats | METHOD FOR DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER METASTASIS |
EP2703005A1 (en) * | 2012-09-04 | 2014-03-05 | Università Degli Studi Di Torino | Inhibitors of alpha6 Integrin/E-Cadherin Complex |
US20150218213A1 (en) * | 2012-09-04 | 2015-08-06 | Università Degli Studi Di Torino | Inhibitors of alpha6 integrin/e-cadherin complex |
US10119171B2 (en) | 2012-10-12 | 2018-11-06 | Inbiomotion S.L. | Method for the diagnosis, prognosis and treatment of prostate cancer metastasis |
EP2906718B1 (en) | 2012-10-12 | 2019-05-15 | Inbiomotion S.L. | Method for the diagnosis, prognosis and treatment of prostate cancer metastasis using c-maf |
KR20150122731A (en) | 2013-03-15 | 2015-11-02 | 펀다시오 인스티튜트 드 르세르카 바이오메디카 (아이알비 바르셀로나) | Method for the prognosis and treatment of cancer metastasis |
KR20150122786A (en) | 2013-03-15 | 2015-11-02 | 펀다시오 인스티튜트 드 르세르카 바이오메디카 (아이알비 바르셀로나) | Method for the diagnosis, prognosis and treatment of cancer metastasis |
WO2014184679A2 (en) | 2013-03-15 | 2014-11-20 | Inbiomotion S.L. | Method for the prognosis and treatment of renal cell carcinoma metastasis |
WO2015052583A2 (en) | 2013-10-09 | 2015-04-16 | Fundacio Institut De Recerca Biomedica (Irb Barcelona) | Method for the prognosis and treatment of cancer metastasis |
EP3229909B1 (en) | 2014-12-11 | 2020-10-14 | Inbiomotion S.L. | Binding members for human c-maf |
EP3090751A1 (en) | 2015-05-06 | 2016-11-09 | Université de Lausanne | Molecular profiling of cd8 t-cells in autochthonous melanoma identifies maf as driver of exhaustion |
MX2018014279A (en) | 2016-05-25 | 2019-07-08 | Inbiomotion Sl | Therapeutic treatment of breast cancer based on c-maf status. |
CA3082728A1 (en) | 2017-11-22 | 2019-05-31 | Inbiomotion S.L. | Therapeutic treatment of breast cancer based on c-maf status |
-
2003
- 2003-10-17 AU AU2003286499A patent/AU2003286499A1/en not_active Abandoned
- 2003-10-17 WO PCT/US2003/033162 patent/WO2005046731A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2005046731A1 (en) | 2005-05-26 |
AU2003286499A8 (en) | 2005-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003272930A1 (en) | Footwere | |
AU2003902455A0 (en) | Cadmas | |
AU2003286499A1 (en) | Interference with c-maf function in multiple myeloma | |
AU2003274573A1 (en) | Deburrer | |
AU2003241210A1 (en) | Videocomputer | |
AU2003232657A1 (en) | Clothing with particular function | |
AU2003100006A4 (en) | Adcaster | |
AU2003100198A4 (en) | Colourband Browbands | |
AU2003100325A4 (en) | Freez-A-Cube | |
AU2003100378A4 (en) | Scootermansydney | |
AU2003100942A4 (en) | Energenz | |
AU2003900402A0 (en) | Stillage | |
AU2003900486A0 (en) | Waterguard house drencher | |
AU2003904561A0 (en) | Not Given | |
AU2003904245A0 (en) | Not given | |
AU2003904212A0 (en) | Not given | |
AU2003903955A0 (en) | Not given | |
AU2003903592A0 (en) | Not given | |
AU2003904076A0 (en) | Find me | |
AU2003905171A0 (en) | Multigame Selection | |
AU2003902029A0 (en) | Ecourinal | |
AU2003900000A0 (en) | Sunergy | |
AU2003902574A0 (en) | La-bp cecurit | |
AU2003903022A0 (en) | Visible-love management-system | |
AU2003900904A0 (en) | Soupermatic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TH | Corrigenda |
Free format text: IN VOL 19, NO 28, PAGE(S) 1859 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF HEALTH AND HUMAN SERVICES, APPLICATION NO. 2003286499, UNDER INID (43) CORRECT THE DATE TO READ 06.06.2005 |
|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |